Browse By: Country ι Category ι Publisher ι Tag

The World Pharmaceutical Markets Fact Book 2013

Pages » N/A
Published By » Espicom
Price » $1545
In stock
View Report Details
Description

The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ideal companion in today’s challenging pharmaceutical market environment. The need to understand world pharmaceutical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive source of key market statistics is an invaluable aid for every pharmaceutical industry executive. Proven and reliable Published by Espicom - experts in the healthcare field for over 30 years, the Fact Book brings together a range of often difficult to source infor... Click here for more details


Breast Cancer Drug Discoveries: What the Future Holds
In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are required to increase survival and delay disease progression. Unique breast cancer market share, sales forecasts by launched and Phase III products to 2
Published Date: Aug 2011
Price: $3145
The Outlook for Pharmaceuticals in Brazil, Russia, India & China
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist for pharmaceutical companies over the 2011-16 forecast period? Putting things in perspective...
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central Asia
These reports analyse the issues These reports provide a detailed analysis of four of the most populous countries in the world and the massive potential of their pharmaceutical markets. The markets of Central Asia contrast well; China and India are two of the largest pharmaceutical markets with ver
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central & Eastern Europe
The pharmaceutical market of Central & Eastern Europe is estimated at US$63.6 billion at retail prices in 2011; it is expected to reach US$104.2 billion by 2016. The market is expected to expand by a moderate CAGR in US dollar terms between 2011 and 2016, as the region’s economies reco
Published Date: Feb 2012
Price: $3630
E7: The Outlook for Pharmaceuticals to 2012
The E7 economies represent increasing opportunities for pharmaceutical companies constrained by maturing markets in the west. Huge potential in E7 markets The emerging E7 countries represent the best prospect for growth. The potential of these countries is huge: they have a combined
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Latin America
Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive The region needs to increase drug access, despite intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin A
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in the Middle East and North Africa
Macro-environmental conditions affected by political unrest In spite of recent political unrest, economic, social and demographic changes are making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence Unit (EIU) forecasts th
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Northern Europe
The Northern European countries are projected to represent a combined pharmaceutical market value of over US$23 billion at retail prices by 2016. The seven Northern European pharmaceutical markets are diverse, from the stable well-developed markets of Scandinavia to the less well-funded
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in South East Asia
The eight pharmaceutical markets of South East Asia are developing at markedly different speeds and are characterised by contrasting macroeconomic factors. These markets are projected to have a combined pharmaceutical market value of US$69.1 billion at retail prices in 2016. Established&hel
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Western Europe
Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly in the hospital market. Growth, however, will be tempered somewhat by the effects of the glob
Published Date: Feb 2012
Price: $3630

 


 

Related News

New Innovations in Optics LED
New innovations in the field of lasers and optics have introduced high density white LED light engines for OEM fiber optic illumination. White light LEDs are rapidly becoming the most preferred source for light guide illumination in several technical applications which were once ruled by HID lamps and tungsten halogen. White LEDs offer operational advantages and substantial cost. LumiBright™ delivers up to 4000 lumens into the light guide. LumiBright have no additional optics and couple
Date: Dec 18

‘Fluctuations in Air Freight Impacts Pharma Supply Chains’
Air freight has been considered to be imperative to the pharmaceutical industry more so as supply chains take on a more complex shape. The Life Science and Pharmaceutical conference held in London on Tuesday stressed upon this very fact. Emerging trends such as healthcare at home, increasing clinical trials across the globe, and advanced therapies as well as companion diagnostics have tremendously changed the pharmaceutical industry, according to David Spillet, key account director at World C
Date: Dec 17

Two AC/DC Drivers Launched by ON
On Semiconductor has recently expanded their product line for NCL3008x by launching two new series of offline AC-DC drivers with Power Factor Correction. Their new line of semiconductors includes the new NCL30085/86/88/30. The NCL30030 widens the existing solutions which support higher power topologies. Their primary purpose would be in high performance LED lighting applications. The new line of PFC drivers are said to be small, robust, and flexible. Three of them use a PF corrected algorithm
Date: Dec 17

Different Prospects of New Nuclear Power
Nuclear energy was once promised as the world’s leading source to provide cheap and safe electrical power. However, The United States has led the way in nuclear research due to government finance and support. Some analysts also claimed that electricity would go meterless in the future.   Nevertheless, things did not turn out as decided due to nuclear waste accumulation, accidents, and safety problems, and most of all – rising costs. Despite these problems, growth in nuclear p
Date: Dec 17

Drop in Oil Prices sets off Alarm Bells in Producers and Shareholders
The well-publicized drop in oil prices this week has been celebrated by the masses all over the world as an answer to years of demands. However, the picture is far from rosy on the other side, as oil exporters and shareholders reacquaint themselves with a sub-$60 per-barrel pricing after a considerable hiatus. Increasing amounts of oil production from countries outside the OPEC (Organization of the Petrol Exporting Countries) is loosening OPEC’s stranglehold over the global petroleum ma
Date: Dec 16

Chinese Construction Shares Rise on Stimulus Bets
For the second consecutive day, China’s stocks have risen, led by railway and construction companies. Their growth has been based on the speculation that the government will take improved steps to support economic growth. China Railway Group Ltd. and China State Construction Engineering Corp. gained more than 7 per cent, enough to lead the rise for infrastructure related companies. Meanwhile, Premier Li Keqiang is visiting Kazakhstan to forge a Silk Road Fund that could finance the buil
Date: Dec 15

Citigroup Charges Investors with US$2.7 Billion for Legal Expenses
Citigroup gave its investors a surprise with its 4th quarter results on Tuesday, with an expected US$2.7 billion legal charge associated with multiple investigations. Citigroup has been discussing for settlement with banking regulators and federal prosecutors over a series of investigations connected to possible manipulation in the lax anti-money-laundering controls and the currency market. The 4th quarter charge also reveals the expected cost of a separate inquiry about the role Citigroup an
Date: Dec 10

After Louisiana-Pacific’s Downgrade - What’s next in the Building and Construction Products Industry?
Louisiana-Pacific Corporation was downgraded by the DA Davidson research firm last Friday from a status of “Buy” to a “Neutral” rating, i.e. LPX 0%. RBC Capital had struck a similar rating a few days earlier. It changed its rating from ‘Sector Perform’ to ‘Underperform’ - where the price target was set as $13.00 per share. These implications apply a downside potential of 22 percent from the present price (as of December 8) of $16.85 per share. 
Date: Dec 09

Southern Company Got Warning from State Monitor on Ga. Nuclear Plant Costs
State monitors has warned Southern Co. that building a multi-billion dollar nuclear plant in Georgia without having a comprehensive construction schedule could cause financial penalties. A report was filed by an analyst and an engineer working for state regulators. They supervise the elevation of two new reactors situated at Plant Vogtle in eastern Georgia. The warning was mentioned in that report. The Public Service Commission has notified for at least two years that Georgia Power, a subs
Date: Dec 08

India to Export Carabeef to Russia
According to some recent talks between India’s (APEDA) and phyto-sanitary watchdog Rosselkhoznadzor, Russia has permitted the imports of buffalo meat (carabeef) from India.  This act falls under the Ministry of Commerce and Industry of India. The move is placed a few days ahead of the Russian President’s visit to India. Rosselkhoznadzor in association with the Ministry of Agriculture of Kazakhstan has involved Indian exporters on its buffalo meat import list.  Compani
Date: Dec 08

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795